A Phase I/II Clinical Trial to Evaluate the Safety and Efficacy of Intramyocardial Injection of Human Umbilical Cord Mesenchymal Stem Cells (HucMSCs) Combined With Coronary Artery Bypass Grafting in the Treatment of Chronic Heart Failure Caused by Chronic Ischemic Cardiomyopathy
Latest Information Update: 22 Jan 2026
At a glance
- Drugs B 2278 (Primary)
- Indications Chronic heart failure
- Focus Adverse reactions
- Sponsors Tasly Pharmaceutical Group
Most Recent Events
- 12 Dec 2025 New trial record